Your browser doesn't support javascript.
loading
Factor V Leiden.
Van Cott, Elizabeth M; Khor, Bernard; Zehnder, James L.
Afiliação
  • Van Cott EM; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.
  • Khor B; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.
  • Zehnder JL; Department of Pathology, Stanford University School of Medicine, Stanford, California.
Am J Hematol ; 91(1): 46-9, 2016 Jan.
Article em En | MEDLINE | ID: mdl-26492443
Factor V Leiden (FVLeiden ) is a common hereditary thrombophilia that causes activated protein C (APC) resistance. This review describes many of the most fascinating features of FVLeiden , including background features, mechanisms of hypercoagulability, the founder mutation concept, the "FVLeiden paradox," synergistic interaction with other thrombotic risk factors, the intertwined relationship between FVLeiden and APC resistance testing, and other, uncommon mutations implicated in causing APC resistance. In addition, there are several conditions where laboratory tests for APC resistance and FVLeiden are or can be discrepant, including lupus anticoagulants, anticoagulants such as direct thrombin inhibitors (dabigatran, argatroban, and bivalirudin) and rivaroxaban, as well as pseudohomozygous, pseudo-wildtype, liver transplant, and bone marrow transplant patients. The laboratory test error rate for FVLeiden is also presented.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator V / Resistência à Proteína C Ativada Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator V / Resistência à Proteína C Ativada Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article